Rentokil Initial plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Rentokil Initial plc, dated April 21, 2023, discloses a transaction by a Person Discharging Managerial Responsibilities (PDMR) in accordance with Article 19 of the UK Market Abuse Regulation. The filing contains inside information regarding the sale of shares by the Company's Chief Executive.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on the details of a specific share transaction.
- Transaction Type: Sale of ordinary shares
- Instrument: Ordinary shares of 1p each (ISIN: GB00B082RF11)
- Volume Sold: 1,025,000 shares
- Transaction Price: 618.9835p per share
- Total Value: £6,344,580.88
- Date of Transaction: April 21, 2023
- Exchange: London Stock Exchange (XLON)
Material Changes and Management Commentary
Andy Ransom, Chief Executive, sold 1,025,000 ordinary shares. The proceeds, after tax, are designated to fund a property purchase. The Company notes that Mr. Ransom has not previously sold any of his shareholding in the 15 years since becoming a Director, except to pay income tax and National Insurance on vesting performance shares. Following this transaction, he retains a beneficial holding of over 6 million ordinary shares held directly or under vested but unexercised Performance Share Plan and Deferred Bonus Plan awards.
Investor Verification Checklist
- Verify the current share price of Rentokil Initial plc to assess the market context of the sale.
- Confirm the total number of shares held by Andy Ransom post-transaction to validate the "over 6 million" claim.
- Review the Company's latest annual report (Form 20-F) for broader financial performance metrics not included in this filing.
- Check for any subsequent filings regarding further PDMR transactions.